日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Association Between Genetic Polymorphisms of UGT1A1, ABCG2, and NR1I2 and Dolutegravir Pharmacokinetic Parameters in Thai People Living with HIV

UGT1A1、ABCG2 和 NR1I2 基因多态性与泰国 HIV 感染者多替拉韦药代动力学参数的关联性研究

Chanruang, Anan; Birnbaum, Angela K; Sirilun, Sasithorn; Chupradit, Suthunya; Ubolyam, Sasiwimol; Hiranburana, Napon; Cho, Yong Soon; Shin, Jae Gook; Avihingsanon, Anchalee; Punyawudho, Baralee

The population pharmacokinetics of dolutegravir co-administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens

多替拉韦与利福平联合用药在泰国HIV感染者中的群体药代动力学:替代给药方案的评估

Punyawudho, Baralee; Chanruang, Anan; Ueaphongsukkit, Thornthun; Gatechompol, Sivaporn; Ubolyam, Sasiwimol; Cho, Yong Soon; Shin, Jae Gook; Avihingsanon, Anchalee

Optimized fosfomycin regimens for treating carbapenem-resistant Acinetobacter baumannii in critically ill patients with varying degrees of renal function

针对肾功能不同程度的危重患者,优化磷霉素治疗耐碳青霉烯类鲍曼不动杆菌感染的方案

Tidwong, Nattapong; Chanruang, Anan; Chupradit, Suthanya; Parker, Suzanne L; Leelawattanachai, Pannee; Winichakoon, Poramed; Punyawudho, Baralee